Adaptive Phage Therapeutics (APT) is a clinical-stage company advancing therapies addressing multi-drug resistant infections. Prior antimicrobial therapeutic approaches have been “fixed,” while pathogens continue to evolve resistance to each of those therapeutics, causing those drug products to become rapidly less effective in commercial use as antimicrobial resistance (AMR) increases over time.

Biotechnology

Adaptive Phage Therapeutics

Adaptive Phage Therapeutics' headquarters in Gaithersburg, MD, United States

Carl R. Merril

Emae Lee-Voritskul, CPA

Dale Eadie

Mike Sowers

Siblian Boston

Lisa Mulcahy

Jonathan Leff

Evan Loh

Martin Heidecker

Raymond D. Martz

Jesse Goodman

The Directors and Managers team at Adaptive Phage Therapeutics oversees the strategic direction, operational management, and clinical research initiatives of the company. Their responsibilities include driving process and analytical development, managing manufacturing operations, coordinating clinical programs, and ensuring effective human resources and project management to advance therapies against multi-drug resistant infections.

Directors and Managers

Adaptive Phage Therapeutics

Org chart

Board & advisors

Teams

Directors and Managers

Offices

Adaptive Phage Therapeutics

Org chart

Board & advisors

Teams

Directors and Managers

Offices

Related companies